A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Conditions
Cardiovascular · Metabolic Disease · Dyslipidemias · Lipid Disorder · Hypertriglyceridemia · Heterozygous Familial Hypercholesterolemia (HeFH) · Homozygous Familial Hypercholesterolemia (HoFH) · Severe Hypertriglyceridemia (sHTG) · Mixed Hyperlipemia · Hypercholesterolaemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research Site 20, Hialeah, Florida, United States
Research Site 19, High Point, Florida, United States
Research Site 10, Jacksonville, Florida, United States
Research Site 17, Orlando, Florida, United States
Research Site 11, Port Orange, Florida, United States
Research Site 21, Rochester, New York, United States
Research Site 14, Durham, North Carolina, United States
Research Site 13, High Point, North Carolina, United States
Research Site 9, Cleveland, Ohio, United States
Research Site 12, Portland, Oregon, United States
Research Site 1, Adelaide, Australia
Research Site 15, Brisbane, Australia
Research Site 16, Brisbane, Australia
Research Site 7, Camperdown, Australia
Research Site 3, Heidelberg, Australia
Research Site 2, Melbourne, Australia
Research Site 5, Auckland, New Zealand
Research Site 4, Christchurch, New Zealand
Research Site 18, Cambridge, United Kingdom
Research Site 8, London, United Kingdom
Research Site 6, London, United Kingdom